Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1490
https://www.valueinhealthjournal.com/article/S1098-3015(17)31824-7/fulltext
Title :
Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31824-7&doi=10.1016/j.jval.2017.08.1490
First page :
A645
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1339